{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:03:45Z","timestamp":1792659825996,"version":"4.5.0"},"reference-count":84,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"DOI":"10.1210\/jc.2012-4070","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T12:31:46Z","timestamp":1363350706000},"page":"1771-1780","source":"Crossref","is-referenced-by-count":98,"title":["Where Are We 10 Years After the Women's Health Initiative?"],"prefix":"10.1210","volume":"98","author":[{"given":"Roger A.","family":"Lobo","sequence":"first","affiliation":[{"name":"Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113275669900_B1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"Stampfer","year":"1991","journal-title":"Prev Med"},{"key":"key\n\t\t\t\t2019041113275669900_B2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","article-title":"Decreased mortality in users of estrogen replacement therapy","volume":"151","author":"Henderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women","volume":"117","author":"Grady","year":"1992","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jwh.1997.6.459","article-title":"Women's beliefs and decisions about hormone replacement therapy","volume":"6","author":"Newton","year":"1997","journal-title":"J Womens Health"},{"key":"key\n\t\t\t\t2019041113275669900_B6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B7","first-page":"61","article-title":"The new conundrum: do estrogens have any cardiovascular benefits?","volume":"47","author":"Clarkson","year":"2002","journal-title":"Int J Fertil Womens Med"},{"key":"key\n\t\t\t\t2019041113275669900_B8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women","volume":"349","author":"Hodis","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2009.05.033","article-title":"Coronary heart disease and menopause management: the swinging pendulum of HRT","volume":"207","author":"Stevenson","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041113275669900_B12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00007611-200295080-00004","article-title":"NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit","volume":"95","year":"2002","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019041113275669900_B13","volume-title":"The hormone decision","author":"Parker-Pope","year":"2007"},{"key":"key\n\t\t\t\t2019041113275669900_B14","first-page":"B1","article-title":"How NIH misread hormone study in 2002","author":"Parker- Pope","year":"2007","journal-title":"The Wall Street Journal"},{"key":"key\n\t\t\t\t2019041113275669900_B15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/gme.0b013e31823a3e5d","article-title":"Evolution of postmenopausal hormone therapy between 2002 and 2009","volume":"19","author":"Ettinger","year":"2012","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e318265df42","article-title":"A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999\u20132010","volume":"120","author":"Sprague","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113275669900_B17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/gme.0b013e31817b816e","article-title":"Trend in incidence of osteoporosis-related fractures among 40-to 69-year-old women: analysis of a large insurance claims database, 2000\u20132005","volume":"16","author":"Islam","year":"2009","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/gme.0b013e31821b01c7","article-title":"Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization","volume":"18","author":"Karim","year":"2011","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease; the Women's Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B20","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/13697137.2011.570590","article-title":"Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health","volume":"14","author":"Sturdee","year":"2011","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t2019041113275669900_B23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/03630242.2012.682705","article-title":"Physical activity, hormone replacement therapy, and the presence of coronary calcium in midlife women","volume":"52","author":"Weinberg","year":"2012","journal-title":"Women Health"},{"key":"key\n\t\t\t\t2019041113275669900_B25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B27","article-title":"Primary findings of the Kronos Early Prevention Study (KEEPS)","author":"Harman"},{"key":"key\n\t\t\t\t2019041113275669900_B28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-135-11-200112040-00005","article-title":"Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial","volume":"135","author":"Hodis","year":"2001","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B29","article-title":"Cognitive and effective substudy (KEEPS Cog)","author":"Asthana"},{"key":"key\n\t\t\t\t2019041113275669900_B30","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"2012 Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial","volume":"345","author":"Schierbeck","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113275669900_B31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2005.06.011","article-title":"The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the Postmenopausal Estrogen Progestin Intervention (PEPI) trial","volume":"185","author":"Hu","year":"2006","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041113275669900_B32","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113275669900_B33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study","volume":"109","author":"Clarke","year":"2002","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041113275669900_B34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.164.5.482","article-title":"Evaluation of cardiovascular event rates with hormone therapy in healthy postmenopausal women: results from four large clinical trials","volume":"164","author":"Lobo","year":"2004","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.gme.0000172880.40831.3b","article-title":"Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study","volume":"13","author":"Paganini-Hill","year":"2006","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","article-title":"Postmenopausal hormone therapy and mortality","volume":"336","author":"Grodstein","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B37","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjmed.2009.05.021","article-title":"Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women","volume":"122","author":"Salpeter","year":"2009","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B38","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/eurheartj\/ehn299","article-title":"Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis","volume":"29","author":"Sare","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113275669900_B39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.168.8.861","article-title":"Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy","volume":"168","author":"Grodstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","article-title":"Effects of conjugated equine estrogen on stroke in the Women's Health Initiative","volume":"113","author":"Hendrix","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113275669900_B41","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/gme.0b013e3181e9e538","article-title":"Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation","volume":"18","author":"Lobo","year":"2011","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B43","doi-asserted-by":"crossref","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113275669900_B44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113275669900_B45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/gme.0b013e3181f9f7c3","article-title":"Hormone therapy and recurrence of venous thromboembolism among postmenopausal women","volume":"18","author":"Olie","year":"2011","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of administration and progestogens: the ESTER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113275669900_B47","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","article-title":"Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study","volume":"10","author":"Sweetland","year":"2012","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t2019041113275669900_B48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2011.10.003","article-title":"Thromboembolic disorders in obstetrics","volume":"26","author":"Gray","year":"2012","journal-title":"Best Practice Res Clin Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041113275669900_B49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10410236.2010.546770","article-title":"Covering women's greatest health fear: breast cancer information in consumer magazines","volume":"26","author":"Walsh-Childers","year":"2011","journal-title":"Health Commun"},{"key":"key\n\t\t\t\t2019041113275669900_B50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen and progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t2019041113275669900_B51","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwn044","article-title":"Estrogen plus progestin therapy and breast cancer in recently postmenopausal women","volume":"167","author":"Prentice","year":"2008","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t2019041113275669900_B53","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/aje\/kwn420","article-title":"Estrogen plus progestin therapy and breast cancer in recently postmenopausal women","volume":"169","author":"Langer","year":"2009","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t2019041113275669900_B54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t2019041113275669900_B55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/1055-9965.EPI-12-0043","article-title":"Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy","volume":"21","author":"Santen","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t2019041113275669900_B56","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomized placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2019041113275669900_B58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1158\/1940-6207.CAPR-11-0185","article-title":"Paradoxical clinical effect of estrogen on breast cancer risk: a \u201cnew\u201d biology of estrogen-induced apoptosis","volume":"4","author":"Jordan","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"key\n\t\t\t\t2019041113275669900_B59","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113275669900_B60","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum, sex hormones and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019041113275669900_B61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/13697137.2011.624215","article-title":"What are the real risks for breast cancer?","volume":"15","author":"Bluming","year":"2012","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t2019041113275669900_B62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/13697137.2012.666456","article-title":"Hormone therapy and breast cancer risk 10 years after the WHI","volume":"15","author":"Gompel","year":"2012","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t2019041113275669900_B63","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.279.9.688","article-title":"Estrogen therapy in postmenopausal women: effects on cognitive function and dementia","volume":"279","author":"Yaffe","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B64","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.285.11.1489","article-title":"Hormone replacement therapy and cognition: systematic review and meta-analysis","volume":"285","author":"LeBlanc","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B65","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B66","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00042192-200512010-00005","article-title":"Early postmenopausal hormone therapy may prevent cognitive impairment later in life","volume":"12","author":"Bagger","year":"2005","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.22239","article-title":"Timing of hormone therapy and dementia: the critical window theory revisited","volume":"69","author":"Whitmer","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t2019041113275669900_B69","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1212\/WNL.0b013e318271f823","article-title":"Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study","volume":"79","author":"Shaott","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019041113275669900_B70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/13697137.2012.655923","article-title":"Quality of life and the role of menopausal hormone therapy","volume":"15","author":"Pines","year":"2012","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t2019041113275669900_B71","first-page":"991","article-title":"Estrogen improves psychological function in asymptomatic postmenopausal women","volume":"78","author":"Ditkoff","year":"1991","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113275669900_B72","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1089\/jwh.2008.1246","article-title":"Cost-effectiveness of hormone therapy in the United States","volume":"18","author":"Lekander","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"key\n\t\t\t\t2019041113275669900_B73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjmed.2008.07.026","article-title":"The cost-effectiveness of hormone therapy in younger and older postmenopausal women","volume":"122","author":"Salpeter","year":"2009","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113275669900_B74","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement","volume":"95","author":"Santen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113275669900_B75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/13697137.2012.659975","article-title":"The WHI: the effect of hormonal replacement therapy on fracture prevention","volume":"15","author":"de Villiers","year":"2012","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t2019041113275669900_B76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of The North American Menopause Society","volume":"19","year":"2012","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041113275669900_B77","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113275669900_B78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-005-0096-0","article-title":"The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomized trial","volume":"49","author":"Bonds","year":"2006","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113275669900_B79","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113275669900_B80","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.109.906479","article-title":"Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials","volume":"121","author":"Mora","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113275669900_B81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2008.08.001","article-title":"Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis","volume":"138","author":"Petretta","year":"2010","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019041113275669900_B82","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2012.216","article-title":"Some question use of statins to reduce cardiovascular risks in healthy women","volume":"307","author":"Mitka","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B83","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113275669900_B84","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","article-title":"Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial","volume":"336","author":"Bolland","year":"2008","journal-title":"BMJ"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/5\/1771\/9044566\/jcem1771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T14:34:56Z","timestamp":1644590096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/5\/1771\/2536695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-4070","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}